SGLT2 inhibitors to prevent diabetic kidney disease (vol 8, pg 4, 2020)

被引:0
|
作者
Fioretto, P.
Vettor, R.
Pontremoli, R.
机构
来源
LANCET DIABETES & ENDOCRINOLOGY | 2020年 / 8卷 / 02期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:E1 / E1
页数:1
相关论文
共 50 条
  • [21] Correction to: SGLT2 inhibitors: a novel choice for the combination therapy in diabetic kidney disease
    Honghong Zou
    Baoqin Zhou
    Gaosi Xu
    Cardiovascular Diabetology, 17
  • [22] Major Advancements in Slowing Diabetic Kidney Disease Progression: Focus on SGLT2 Inhibitors
    Bakris, George L.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2019, 74 (05) : 573 - 575
  • [23] Is the joint use of diuretics and SGLT2 inhibitors beneficial in diabetic kidney disease? reply
    Mayer, Gert J.
    Wanner, Christoph
    Weir, Matthew R.
    Inzucchi, Silvio E.
    Koitka-Weber, Audrey
    Hantel, Stefan
    von Eynatten, Maximilian
    Zinman, Bernard
    Cherney, David Z. I.
    KIDNEY INTERNATIONAL, 2020, 97 (01) : 213 - 214
  • [24] A real-world study on SGLT2 inhibitors and diabetic kidney disease progression
    Liu, Allen Yan Lun
    Low, Serena
    Yeoh, Ester
    Lim, Eng Kuang
    Renaud, Claude Jeffrey
    Teoh, Selene Tse Yen
    Tan, Grace Feng Ling
    Chai, Chung Cheen
    Liu, Bo
    Subramaniam, Tavintharan
    Sum, Chee Fang
    Lim, Su Chi
    CLINICAL KIDNEY JOURNAL, 2022, 15 (07) : 1403 - 1414
  • [25] SGLT2 and cancer (vol 472, pg 1407, 2020)
    Wright, Ernest M.
    PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 2021, 473 (11): : 1807 - 1807
  • [26] SGLT2 Inhibitors across the Spectrum of Severity of CKD (vol 15, pg 1386, 2020)
    Ziaolhagh, Ali
    Argyropoulos, Christos
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 16 (01): : 127 - 127
  • [27] Diabetic ketoacidosis with SGLT2 inhibitors
    Musso, Giovanni
    Saba, Francesca
    Cassader, Maurizio
    Gambino, Roberto
    BMJ-BRITISH MEDICAL JOURNAL, 2020, 371
  • [28] SGLT2 inhibitors for heart and kidney
    van der Giet, Markus
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2023, 148 (22) : 1456 - 1461
  • [29] SGLT2 Inhibitors and Kidney Outcomes in Patients with Chronic Kidney Disease
    Kanduri, Swetha R.
    Kovvuru, Karthik
    Hansrivijit, Panupong
    Thongprayoon, Charat
    Vallabhajosyula, Saraschandra
    Pivovarova, Aleksandra I.
    Chewcharat, Api
    Garla, Vishnu
    Medaura, Juan
    Cheungpasitporn, Wisit
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (09)
  • [30] SGLT2 inhibitors: β blockers for the kidney?
    Gilbert, Richard E.
    LANCET DIABETES & ENDOCRINOLOGY, 2016, 4 (10): : 814 - 814